Event Date: 18/10/2017 18:00
Are you a healthcare professional interested in finding out more about biosimilar medicines?
The HPRA is hosting an information evening to explain how biosimilar medicines are approved for use in patients.
The evening will consist of a series of presentations from HPRA experts outlining the quality, non-clinical and clinical data requirements for biosimilar medicines. In addition pharmacovigilance, interchangeability and international trends related to the use of biosimilar medicines will be discussed.
The session will conclude with a Q&A, where you will have an opportunity to ask any questions you may have.
The information evening will be held on the 18th October in the HPRA office in Dublin from 6pm to 8pm
Dr. Una Moore – Overview of biological and biosimilar medicines
Dr. Sean Barry – Quality and non-clinical data requirements for biosimilars
Dr. Sandra Bright – Clinical data requirements for biosimilars
Dr. Emma Lawless – Pharmacovigilance
Ms. Joan O’Callaghan – International trends and Interchangeability
Dr. Anthony O’Connor - Biosimilars in Ireland: The physician perspective
To register please click on the below link: